Tomoko  Yamagishi-Dressler net worth and biography

Tomoko Yamagishi-Dressler Biography and Net Worth

CMO of Evolus

Tomoko Yamagishi-Dressler has served as our Chief Marketing Officer since 2023. Previously, she was Global Chief Marketing Officer at Beautyblender where she elevated their global market position and drove category leadership for the brand’s namesake makeup tool in Sephora and ULTA stores across the United States. From 2000 to 2020, Tomoko held increasing roles of responsibility at Shiseido, one of the world’s top 10 beauty companies. Earlier in her career, she worked at Chanel Inc. and Victoria’s Secret Beauty Company. With extensive experience in global finance, she has also managed client portfolios for top financial institutions as the former VP of Fixed Income at Lehman Brothers. Tomoko holds an M.B.A. from Harvard Business School and now serves on the Women’s Alumnae Board.

What is Tomoko Yamagishi-Dressler's net worth?

The estimated net worth of Tomoko Yamagishi-Dressler is at least $612.55 thousand as of August 22nd, 2025. Yamagishi-Dressler owns 89,949 shares of Evolus stock worth more than $612,553 as of December 5th. This net worth approximation does not reflect any other assets that Yamagishi-Dressler may own. Learn More about Tomoko Yamagishi-Dressler's net worth.

How do I contact Tomoko Yamagishi-Dressler?

The corporate mailing address for Yamagishi-Dressler and other Evolus executives is 520 Newport Center Dr. Suite 1200, Newport Beach CA, 92660. Evolus can also be reached via phone at (949) 284-4555 and via email at [email protected]. Learn More on Tomoko Yamagishi-Dressler's contact information.

Has Tomoko Yamagishi-Dressler been buying or selling shares of Evolus?

Tomoko Yamagishi-Dressler has not been actively trading shares of Evolus in the last ninety days. Most recently, Tomoko Yamagishi-Dressler sold 5,722 shares of the business's stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $7.51, for a transaction totalling $42,972.22. Following the completion of the sale, the chief marketing officer now directly owns 89,949 shares of the company's stock, valued at $675,516.99. Learn More on Tomoko Yamagishi-Dressler's trading history.

Who are Evolus' active insiders?

Evolus' insider roster includes Rui Avelar (Insider), David Gill (Director), David Gill (Director), Vikram Malik (Director), David Moatazedi (Insider), Albert White, III (Director), and Tomoko Yamagishi-Dressler (CMO). Learn More on Evolus' active insiders.

Are insiders buying or selling shares of Evolus?

During the last twelve months, Evolus insiders bought shares 2 times. They purchased a total of 50,000 shares worth more than $393,600.00. During the last twelve months, insiders at the sold shares 13 times. They sold a total of 223,706 shares worth more than $2,416,073.05. The most recent insider tranaction occured on August, 22nd when CMO Tomoko Yamagishi-Dressler sold 5,722 shares worth more than $42,972.22. Insiders at Evolus own 5.9% of the company. Learn More about insider trades at Evolus.

Information on this page was last updated on 8/22/2025.

Tomoko Yamagishi-Dressler Insider Trading History at Evolus

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/22/2025Sell5,722$7.51$42,972.2289,949View SEC Filing Icon  
3/18/2025Sell4,536$13.26$60,147.3695,671View SEC Filing Icon  
8/30/2024Sell5,631$15.85$89,251.3582,375View SEC Filing Icon  
See Full Table

Tomoko Yamagishi-Dressler Buying and Selling Activity at Evolus

This chart shows Tomoko Yamagishi-Dressler's buying and selling at Evolus by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Evolus Company Overview

Evolus logo
Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Read More

Today's Range

Now: $6.81
Low: $6.69
High: $6.85

50 Day Range

MA: $6.67
Low: $5.99
High: $7.37

2 Week Range

Now: $6.81
Low: $5.71
High: $17.12

Volume

541,556 shs

Average Volume

1,639,299 shs

Market Capitalization

$441.42 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.87